We therefore evaluated the effect of Antho 50 treatment on the expression of two major members of the Bcl-2 family, Bcl-2 and p-Bad in cells from 3 CLL patients. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.